NDC 71335-0787

Terazosin Hydrochloride Anhydrous

Terazosin Hydrochloride Anhydrous

Terazosin Hydrochloride Anhydrous is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Terazosin Hydrochloride.

Product ID71335-0787_4a6920b3-17e8-4c74-a859-fddc3c935dd0
NDC71335-0787
Product TypeHuman Prescription Drug
Proprietary NameTerazosin Hydrochloride Anhydrous
Generic NameTerazosin Hydrochloride Anhydrous
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2000-02-22
Marketing CategoryANDA / ANDA
Application NumberANDA075140
Labeler NameBryant Ranch Prepack
Substance NameTERAZOSIN HYDROCHLORIDE
Active Ingredient Strength1 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71335-0787-1

150 CAPSULE in 1 BOTTLE (71335-0787-1)
Marketing Start Date2000-02-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-0787-6 [71335078706]

Terazosin Hydrochloride Anhydrous CAPSULE
Marketing CategoryANDA
Application NumberANDA075140
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-04-23

NDC 71335-0787-1 [71335078701]

Terazosin Hydrochloride Anhydrous CAPSULE
Marketing CategoryANDA
Application NumberANDA075140
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2000-02-22

NDC 71335-0787-4 [71335078704]

Terazosin Hydrochloride Anhydrous CAPSULE
Marketing CategoryANDA
Application NumberANDA075140
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2000-02-22

NDC 71335-0787-5 [71335078705]

Terazosin Hydrochloride Anhydrous CAPSULE
Marketing CategoryANDA
Application NumberANDA075140
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2000-02-22

NDC 71335-0787-2 [71335078702]

Terazosin Hydrochloride Anhydrous CAPSULE
Marketing CategoryANDA
Application NumberANDA075140
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2000-02-22

NDC 71335-0787-3 [71335078703]

Terazosin Hydrochloride Anhydrous CAPSULE
Marketing CategoryANDA
Application NumberANDA075140
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2000-02-22

Drug Details

Active Ingredients

IngredientStrength
TERAZOSIN HYDROCHLORIDE1 mg/1

OpenFDA Data

SPL SET ID:775763d0-4d9d-4f37-80e7-33289fff73aa
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 313215

    • Pharmacological Class

    • Adrenergic alpha-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]

    NDC Crossover Matching brand name "Terazosin Hydrochloride Anhydrous" or generic name "Terazosin Hydrochloride Anhydrous"

    NDCBrand NameGeneric Name
    0378-1570Terazosin Hydrochloride Anhydrousterazosin hydrochloride anhydrous
    0378-2260Terazosin Hydrochloride Anhydrousterazosin hydrochloride anhydrous
    0378-2264Terazosin Hydrochloride Anhydrousterazosin hydrochloride anhydrous
    0378-2268Terazosin Hydrochloride Anhydrousterazosin hydrochloride anhydrous
    43063-495Terazosin Hydrochloride Anhydrousterazosin hydrochloride anhydrous
    51079-936Terazosin Hydrochloride Anhydrousterazosin hydrochloride anhydrous
    51079-937Terazosin Hydrochloride Anhydrousterazosin hydrochloride anhydrous
    51079-938Terazosin Hydrochloride Anhydrousterazosin hydrochloride anhydrous
    71335-0787Terazosin Hydrochloride Anhydrousterazosin hydrochloride anhydrous
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.